NBCA LIQUID EMBOLIC KIT 631XXX

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,03,05,07 report with the FDA on 2013-07-17 for NBCA LIQUID EMBOLIC KIT 631XXX manufactured by Cordis Neurovascular, Inc..

Event Text Entries

[3653909] Marine, l. , et al? Glue embolus complicating the endovascular treatment of a patient with loeys-dietz syndrome? , j. Vascsurg 2010;52:1350-3 report that nbca glue embolized to the brachial artery during off label use of nbca glue to fill a subclavian pseudoaneurysm while using an opta angioplasty to cover the neck. A vein bypass was required and the patient was discharged asymptomatic with a palpable radial pulse. The patient was diagnosed with loeys-dietz syndrome and presented with a symptomatic 2. 6 cm subclavian pseudoaneurysm. Extensive staged coil embolization of proximal left subclavian branches including the vertebral, internal mammary, and thyrocervical trunk arteries was also required to insure against pseudoaneurysm enlargement or rupture secondary to a type ii endoleak. Catheter directed nbca sac embolization was done for complete ablation of the pseudoaneurysm sac and any remnant small branches. An 8mmx4cm opta balloon angioplasty catheter was inflated to cover the neck of the aneurysm during nbca embolization. The glue was diluted 1:1 and instilled via a coaxial mc with a total of 1. 5ml instilled. During deflation of the balloon, a small amount of glue debris was noted going down the subclavian artery to the brachial artery. The brachial artery was immediately clamped with sheath removal and a 10mmx5cm viabahn stent graft was deployed excluding the left subclavia.
Patient Sequence No: 1, Text Type: D, B5


[10965682] The product was not returned and there was no sterile lot number information reported thus no dhr maybe performed. Additional information will be submitted within 30 days of receipt.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1058196-2013-00188
MDR Report Key3231131
Report Source01,03,05,07
Date Received2013-07-17
Date of Report2013-06-25
Date of Event2010-05-10
Date Mfgr Received2013-06-25
Date Added to Maude2013-07-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMR. MATTHEW KING
Manufacturer CityMIAMI LAKES FL 33014
Manufacturer Postal33014
Manufacturer Phone5088283106
Manufacturer G1CODMAN AND SHURTLEFF, INC
Manufacturer Street325 PARAMOUNT DRIVE
Manufacturer CityRAYNHAM MA 02767
Manufacturer CountryUS
Manufacturer Postal Code02767
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNBCA LIQUID EMBOLIC KIT
Generic NameCNV_NBCA (MFE)
Product CodeKGG
Date Received2013-07-17
Model NumberNA
Catalog Number631XXX
Lot NumberUNK
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCORDIS NEUROVASCULAR, INC.
Manufacturer Address14700 NW 57TH COURT MIAMI LAKES FL 33014 US 33014


Patients

Patient NumberTreatmentOutcomeDate
181. Life Threatening 2013-07-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.